Unravelling The Tumour Immune-Biology Of Ovarian Cancer KU Leuven
Ovarian cancer is the fifth most lethal cancer for woman. It is a silent killer, metastasizing throughout the abdomen before causing symptoms. Consequently, over 70% of patients are diagnosed in advanced disease stages (FIGO stage III to IV). Cytoreductive surgery in combination with platinum-based chemotherapy remain the cornerstones in first-line therapy. However, risk of recurrence is high. Recently approved targeted therapies (anti-VEGF ...